Log in to save to my catalogue

Persistent Nigrostriatal Dopaminergic Abnormalities in Ex-Users of MDMA ('Ecstasy'): An super(18)F-D...

Persistent Nigrostriatal Dopaminergic Abnormalities in Ex-Users of MDMA ('Ecstasy'): An super(18)F-D...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_907158069

Persistent Nigrostriatal Dopaminergic Abnormalities in Ex-Users of MDMA ('Ecstasy'): An super(18)F-Dopa PET Study

About this item

Full title

Persistent Nigrostriatal Dopaminergic Abnormalities in Ex-Users of MDMA ('Ecstasy'): An super(18)F-Dopa PET Study

Journal title

Neuropsychopharmacology (New York, N.Y.), 2011-03, Vol.36 (4), p.735-743

Language

English

Formats

More information

Scope and Contents

Contents

Ecstasy ( plus or minus 3,4-methylenedioxymethamphetamine, MDMA) is a popular recreational drug with known serotonergic neurotoxicity. Its long-term effects on dopaminergic function are less certain. Studying the long-term effects of ecstasy is often confounded by concomitant polydrug use and the short duration of abstinence. We used super(18)F-dop...

Alternative Titles

Full title

Persistent Nigrostriatal Dopaminergic Abnormalities in Ex-Users of MDMA ('Ecstasy'): An super(18)F-Dopa PET Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_907158069

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_907158069

Other Identifiers

ISSN

0893-133X

DOI

10.1038/npp.2010.201

How to access this item